ArticleBiology direct2026
Isolation and characterization of novel bacteriophages with broad-spectrum lytic activity against carbapenem-resistant Klebsiella pneumoniae capsular pathotypes K1, K2, K3, K5, and K20.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCarbapenem-resistant Klebsiella pneumoniae (CRKP), particularly strains associated with virulent capsular pathotypes K1, K2, K3, K5, and K20, represent a major global health burden due to limited therapeutic options and poor clinical outcomes. This study aimed to isolate and characterize lytic bacteriophages targeting clinically relevant CRKP capsular types.
methodsBacteriophages were isolated from hospital sewage and purified by successive plaque assays. Biological characterization included adsorption kinetics, one-step growth analysis, and host range determination. TEM was used for morphological classification. Molecular characterization of the phages was achieved using whole-genome sequencing (WGS).
resultsThree phages, designated UGKSKpnP1, UGKSKpnP2, and UGKSKpnP3, were isolated. The phages exhibited a high and rapid adsorption rate of ~ 95% within 9–10.5 min, short latent periods (~ 25 min), and large burst sizes exceeding 300 PFU/infected cell. All phages efficiently lysed CRKP capsular types K1, K2, K3, K5, and K20. TEM analysis revealed that the phages exhibited siphovirus-like morphology, characterized by similar capsid–tail architecture with polyhedral heads and long non-contractile tails. Based on the current ICTV taxonomy, they were classified within the class Caudoviricetes and the family Drexlerviridae. WGS showed that UGKSKpnP1, UGKSKpnP2, and UGKSKpnP3 possess nearly identical genome sizes of 51,620 bp, 51,622 bp, and 51,622 bp, respectively, with high intra-group average nucleotide similarity (> 99% ANI) and were devoid of tRNA genes, lysogenic markers, virulence factors, and antibiotic-resistance determinants. Phylogenomic and VIRIDIC analyses placed the phages within the family Drexlerviridae and genus Webervirus, and revealed that the phages represent novel species within the Webervirus genus.
conclusionTherefore, UGKSKpnP1, UGKSKpnP2, and UGKSKpnP3 demonstrated strong lytic activity, favorable replication dynamics, and genomic safety, underscoring their potential as candidates for phage therapy against CRKP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.